FDA Clears Breztri for Asthma Use - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA Clears Breztri for Asthma Use

Single-inhaler triple therapy improved lung function vs dual therapy in phase 3 trials and showed rapid onset without new safety signals.

  • By

  • Kathryn Wighton

  • April 28, 2026

  • 2 min

Share

Original Source(s)

FDA Clears Breztri for Asthma Use

  • by Kathryn Wighton

  • April 28, 2026

Related Content

Low Weight Linked to Severe Pediatric COVID

Brazilian pediatric intensive care unit study found underweight status was associated with respiratory complications, longer hospitalization, and mortality among critically ill patients with COVID-19.

What Parents Need to Know About Screening for Cystic Fibrosis in Newborns

FDA Cites Manufacturing Issues for Cytisinicline

Application supported by Phase 3 smoking-cessation data and long-term safety findings.